PMID- 28399115 OWN - NLM STAT- MEDLINE DCOM- 20180516 LR - 20211204 IS - 1530-0447 (Electronic) IS - 0031-3998 (Print) IS - 0031-3998 (Linking) VI - 82 IP - 3 DP - 2017 Sep TI - Neonatal mouse hippocampus: phlebotomy-induced anemia diminishes and treatment with erythropoietin partially rescues mammalian target of rapamycin signaling. PG - 501-508 LID - 10.1038/pr.2017.88 [doi] AB - BackgroundPhlebotomy-induced anemia (PIA) is common in premature infants and affects neurodevelopment. PIA alters hippocampal metabolism in neonatal mice through tissue hypoxia and iron deficiency. The mammalian target of rapamycin (mTOR) pathway senses the status of critical metabolites (e.g., oxygen, iron), thereby regulating hippocampal growth and function. We determined the effect of PIA and recombinant human erythropoietin (rHuEpo) treatment on mTOR signaling and expression of genes related to mTOR pathway functions.MethodsMice receiving an iron-supplemented diet were phlebotomized from postnatal day (P)3 to a target hematocrit of <25% by P7. Half were maintained at <25% until P14; half received rHuEpo from P7 to increase the hematocrit to 25-28%. Hippocampal phosphorylated to total protein ratios of four key mTOR pathway proteins were measured by western blotting at P14 and compared with non-phlebotomized, non-anemic control mice. mRNA levels of genes regulated by mTOR were measured by quantitative PCR.ResultsPIA suppressed phosphorylation of all mTOR proteins. rHuEpo restored AMP-activated protein kinase (AMPK) and AKT status, and partially rescued the mTOR output protein S6K. PIA and rHuEpo treatment also altered the expression of genes regulated by S6K.ConclusionPIA compromises and rHuEpo treatment partially rescues a pathway regulating neuronal DNA transcription, protein translation, and structural complexity. FAU - Wallin, Diana J AU - Wallin DJ AD - Graduate Program in Neuroscience, Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota. FAU - Zamora, Tara G AU - Zamora TG AD - Children's Hospitals and Clinics of Minnesota, St. Paul, Minnesota. FAU - Alexander, Michelle AU - Alexander M AD - Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. FAU - Ennis, Kathleen M AU - Ennis KM AD - Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. FAU - Tran, Phu V AU - Tran PV AD - Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. FAU - Georgieff, Michael K AU - Georgieff MK AD - Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. LA - eng GR - P01 HL046925/HL/NHLBI NIH HHS/United States GR - R01 HD029421/HD/NICHD NIH HHS/United States GR - T32 GM008471/GM/NIGMS NIH HHS/United States GR - UL1 TR000114/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20170531 PL - United States TA - Pediatr Res JT - Pediatric research JID - 0100714 RN - 11096-26-7 (Erythropoietin) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Anemia/*drug therapy/etiology MH - Animals MH - *Animals, Newborn MH - Erythropoietin/*administration & dosage/*therapeutic use MH - Female MH - Hippocampus/*pathology MH - Mice MH - Mice, Inbred C57BL MH - Phlebotomy/*adverse effects MH - Pregnancy MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC5570638 MID - NIHMS863443 COIS- The authors have no financial ties or conflicts of interest to disclose. EDAT- 2017/04/12 06:00 MHDA- 2018/05/17 06:00 PMCR- 2017/11/30 CRDT- 2017/04/12 06:00 PHST- 2016/10/12 00:00 [received] PHST- 2017/03/17 00:00 [accepted] PHST- 2017/04/12 06:00 [pubmed] PHST- 2018/05/17 06:00 [medline] PHST- 2017/04/12 06:00 [entrez] PHST- 2017/11/30 00:00 [pmc-release] AID - pr201788 [pii] AID - 10.1038/pr.2017.88 [doi] PST - ppublish SO - Pediatr Res. 2017 Sep;82(3):501-508. doi: 10.1038/pr.2017.88. Epub 2017 May 31.